Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...

You'll get access to an ad-free website with a faster photo browser, the chance to claim free tickets to a host of events ...

A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

Sundowning is a common symptom in people with dementia, especially Alzheimer’s disease. It refers to a pattern where someone ...

In summary, while there is no guaranteed way to prevent dementia, taking blood pressure medication as prescribed may help ...